
Health Policy vs. Health Politics |
By Kevin Schulman, M.D. The policy goals for health care reform are so clear it should be easy: 1) improve access to health care services — defined as access to insurance; 2) improve the quality of health care services — through health IT; and 3) reduce the cost of health care — through competition or structural changes in the system, such as reform of the small group market. From a policy standpoint, we can debate the intricacies of these various issues and use data or theory to support our arguments. What is happening now in Washington is not health policy, but health politics. Politicians are searching for policies that would gain the most political support (or looking to offer promises to specific members to make the rest of the program more palatable to them). Negotiations are not with the public over the broad agenda, but with specific political interest groups that constitute the Washington lobby core. This is the legislative process of the US at its most transparent. The populist rhetoric has been lost in the tricky business of legislation, lobbying, and politics.
All of us have had our own ideas of where health care reform would take the country, and our opinions about the best way to proceed. We’ll see how this all turns out over the summer, but the one thing is certain — none of us can predict what might be the final proposal from Congress, assuming that there is a final legislative proposal coming forward (note there was not a proposal in 1994 despite a great effort by the Clinton administration to push health care reform). Late last week, the Congressional Budget Office highlighted the obvious, that the program as currently outlined does not do enough to constrain the cost of health care in the US. Obviously, this is a very attractive proposition to the health care community (even the AMA has endorsed some of this legislation), but one would think that the beneficiaries of our massive health care system are the last community we’d want to be happy with this reform effort, if we really are going to change direction within the system. You might notice a new story from Massachusetts calling for a reform in provider payments within that state. Massachusetts passed a health reform plan a few years ago which in many ways is a model for the current Federal legislation. To keep the program politically viable, they increased access without implementing major cost control mechanisms. The result was an acceleration of health care spending in the state. Now a special commission has recommended major changes to the payment systems for providers and incentives for providers to join networks as cost control mechanisms. There appears to be a major concern within some segments of the Democratic Party over the cost of the current program and lack of attention to fiscal responsibility in the plan. President Obama’s campaign stated that people were uninsured because the cost of health care was too great. We’ll see if he returns to that rhetoric as the political process continues to move forward on health care reform. |

I agree with your assessment of the “politics vs policies” issue with respect to healthcare. The largest number of Americans will be served by improved access – portable insurance plans, reduction in or elimination of pre-existing conditions, and the ability of individuals or families to join together with others in a co-op that can qualify for group rates when there are no insurance options otherwise available. If we could just get Congress to start here and show that they could get this access problem fixed first, the more complex and expensive issues can be worked out with greater confidence in the ability and competence of the Federal government to offer a workable solution. Anyone who has had the misfortunate to file for reimbursement through Medicare or Medicaid can understand what inefficiency and ineffectiveness is all about in the central run system.
I am the CEO of a venture funded biotech company. We discontinued company paid health insurance benefits at the beginning of this year as our financial ability to continue to pay decreased with no near term availability of funds for re-capitalization. If we would been required by Federal law to provide healthcare insurance or face fines/surtaxes instead, we would have been bankrupt by now.
Having spent my entire career in pharmaceutical R&D, I favor Federal law that prohibits direct advertising of prescription drug products to patients because the risk to benefit of these products is too complex to explain in a one minute TV ad and to be understood about most patients. I would like to see some of the money now spent on these ads channeled into a pool of funds available for innovation of new therapeutic products and devices or to help make needed pharmaceutical affordable for the poor and elderly.
The frustrating part of what we are watching happen in Congress today is the seemingly hopeless situation of finding a way to get our representatives focused on what we really need versus what we would like to have but probably cannot afford.
Steve Hutcherson
Fuqua EMBA 1979